How Blocscale Launchpad on XRP will Accelerate Innovation on Artificial Intelligence with Its Decentralized Fundraising Platform, Join $BLOC Private Sale To Become an Early Investor In The Blocscale Ecosystem
LIJA, Malta, Jan. 27, 2025 (GLOBE NEWSWIRE) -- The rapid development of…
SQ INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Block, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK--(BUSINESS WIRE)--$SQ #Block--Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally…
PCRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Pacira BioSciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK--(BUSINESS WIRE)--$PCRX #PCRX--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized…
NVO INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO--(BUSINESS WIRE)--The law firm of Robbins Geller Rudman & Dowd LLP…
U-Haul Holding Company Schedules Third Quarter Fiscal 2025 Financial Results Release and Investor Webcast
RENO, Nev.--(BUSINESS WIRE)--U-Haul Holding Company (NYSE: UHAL, UHAL.B), the parent company of…
RVNC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Revance Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK--(BUSINESS WIRE)--$RVNC #RVNC--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized…
Advanced Energy to Participate at Upcoming Investor Conferences
DENVER--(BUSINESS WIRE)--Advanced Energy (Nasdaq: AEIS), a global leader in highly engineered, precision…
AZN INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO--(BUSINESS WIRE)--The law firm of Robbins Geller Rudman & Dowd LLP…
ACELYRIN, INC. to Host Virtual Investor Event to Share new Phase 2 Data and Phase 3 Program Design for Subcutaneous Lonigutamab
January 02, 2025 20:00 ET | Source: ACELYRIN, INC. LOS ANGELES, Jan.…
Veeco Announces Upcoming Investor Event
January 02, 2025 16:05 ET | Source: Veeco Instruments Inc. PLAINVIEW, N.Y.,…